TEVA
LOW Impact
TEVA
Teva Pharmaceutical Announces Q2 2025 Financial Results
|
8-K
Summary
On July 30, 2025, Teva Pharmaceutical Industries Ltd. announced its financial results for the second quarter of 2025. The press release provided details on the company's performance, but specific financial metrics or outcomes were not detailed in the exhibit. The financial statements and exhibits were furnished as part of the report.
Profitelligence Alerts
Get alerts for TEVA
Be first to know when TEVA files with the SEC.
Filing Categories
General Statement
Exhibits Furnished
Exhibits (1)
Advertisement
Official SEC Documents
TEVA Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings
Advertisement